Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

Overview of attention for article published in Clinical Rheumatology, April 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 10,024 followers.

HBV既感染の関節リウマチ患者において、従来型のcDMARDs使用は生物学的製剤使用と比較して、HBV再活性化リスクは低い。 https://t.co/tDEki8XFrq

RT @HepBFoundation: Study of #HBV reactivation risk in rheumatoid arthritis patients who received antirheumatic drugs http://t.co/jLy1di2P

Study of #HBV reactivation risk in rheumatoid arthritis patients who received antirheumatic drugs http://t.co/56fhmLfF